{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:26:21Z","timestamp":1762079181604},"publisher-location":"Berlin, Heidelberg","reference-count":61,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540889540"},{"type":"electronic","value":"9783540889557"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-88955-7_15","type":"book-chapter","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T22:02:39Z","timestamp":1250114559000},"page":"373-385","source":"Crossref","is-referenced-by-count":5,"title":["Feeding Disorders and Obesity"],"prefix":"10.1007","author":[{"given":"Cristina","family":"Cervino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"15_CR1_15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cmet.2007.11.012","volume":"7","author":"C Addy","year":"2008","unstructured":"Addy C, Wright H, Van Laere K et al. (2008) The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab 7:68\u201378","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"15_CR2_15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1365-2826.2008.01682.x","volume":"20","author":"L Bellocchio","year":"2008","unstructured":"Bellocchio L, Cervino C, Vicennati V et al. (2008) Cannabinoid type 1 receptor: another arrow in the adipocytes\u2019 bow. J Neuroendocrinol 20(Suppl 1):130\u2013138","journal-title":"J Neuroendocrinol"},{"key":"15_CR3_15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M Bensaid","year":"2003","unstructured":"Bensaid M, Gary-Bobo M, Esclangon A et al. (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol Pharmacol 63:908\u2013914","journal-title":"Mol Pharmacol"},{"key":"15_CR4_15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejphar.2005.12.016","volume":"531","author":"FJ Bermudez-Silva","year":"2006","unstructured":"Bermudez-Silva FJ, Serrano A, Diaz-Molina FJ et al. (2006) Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 531:282\u2013284","journal-title":"Eur J Pharmacol"},{"key":"15_CR5_15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-007-0890-y","volume":"51","author":"FJ Bermudez-Silva","year":"2008","unstructured":"Bermudez-Silva FJ, Suarez J, Baixeras E et al. (2008) Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 51:476\u2013487","journal-title":"Diabetologia"},{"key":"15_CR6_15","first-page":"3353","volume":"5","author":"M Bluher","year":"2006","unstructured":"Bluher M, Engeli S, Kloting N et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 5:3353\u20133360","journal-title":"Diabetes"},{"key":"15_CR7_15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejphar.2005.05.032","volume":"517","author":"M Bouaboula","year":"2005","unstructured":"Bouaboula M, Hilairet S, Marchand J et al. (2005) Anandamide induced PPAR gamma transcriptional activation and 3T3\u2013L1 preadipocyte differentiation. Eur J Pharmacol 517:174\u2013181","journal-title":"Eur J Pharmacol"},{"key":"15_CR8_15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2006.12.038","volume":"267","author":"P Cavuoto","year":"2007","unstructured":"Cavuoto P, McAincha AJ, Hatzinikolas G et al. (2007) Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrin 267:63\u201369","journal-title":"Mol Cell Endocrin"},{"key":"15_CR9_15","unstructured":"Chew P (2007) Clinical safety. Presented to the Endocrinologic and Metabolic Drugs Advisory Committee, FDA, June 13, 2007. Available at \n                    www.fda.gov\/ohrms\/dockets\/ac\/07\/slides\/2007-4306s1-05-Sanofi-Aventis\n                    \n                   Chew.pdf (slides MM-95, MM-109), accessed Dec 15, 2007"},{"key":"15_CR10_15","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","volume":"370","author":"R Christensen","year":"2007","unstructured":"Christensen R, Kristensen PK, Bartels EM et al. (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706\u20131713","journal-title":"Lancet"},{"key":"15_CR11_15","doi-asserted-by":"publisher","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","volume":"63","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Diaz G et al. (1998) Appetite suppression and weight gain loss after the cannabinoid antagonist SR141716. Life Sci 63:PL113\u2013PL117","journal-title":"Life Sci"},{"key":"15_CR12_15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","volume":"112","author":"D Cota","year":"2003","unstructured":"Cota D, Marsicano G, Tschoep M et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423\u2013431","journal-title":"J Clin Invest"},{"key":"15_CR13_15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","volume":"5","author":"D Cota","year":"2006","unstructured":"Cota D, Tschoep M, Horvath TL et al. (2006) Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 5:85\u2013107","journal-title":"Brain Res Rev"},{"key":"15_CR14_15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","volume":"31","author":"M C\u00f4t\u00e8","year":"2007","unstructured":"C\u00f4t\u00e8 M, Matias I, Lemieux I et al. (2007) Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obesity 31:692\u2013699","journal-title":"Int J Obesity"},{"key":"15_CR15_15","first-page":"172","volume":"6","author":"H Dernbach","year":"2005","unstructured":"Dernbach H, Haller J, Kaulisch T et al. (2005) Effects of the CB1 antagonist SR141716A (Rimonabant) on energy expenditure and respiratory quotient in diet-induced obese rats. Obesity Rev 6:172\u2013173","journal-title":"Obesity Rev"},{"key":"15_CR16_15","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa044537","volume":"353","author":"Despr\u00e9s JP, Golay A, Sj\u00f6str\u00f6m L for the Rimonabant in Obesity-Lipids Study Group","year":"2005","unstructured":"Despr\u00e9s JP, Golay A, Sj\u00f6str\u00f6m L for the Rimonabant in Obesity-Lipids Study Group (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353:2121\u20132134","journal-title":"N Engl J Med"},{"key":"15_CR17_15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Marzo Di","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822\u2013825","journal-title":"Nature"},{"key":"15_CR18_15","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","volume":"23","author":"S Di","year":"2003","unstructured":"Di S, Malcher-Lopes R, Halmos KC et al. (2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850\u20134857","journal-title":"J Neurosci"},{"key":"15_CR19_15","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Feldpausch M et al. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54:2838\u20132843","journal-title":"Diabetes"},{"key":"15_CR20_15","first-page":"520","volume":"143","author":"KM Gamber","year":"2005","unstructured":"Gamber KM, Macartur H, Westfall TC (2005) Cannabinoids augment the release of neuropeptide Y in the rat hypotalamus. Neuropharmacology 143:520\u2013523","journal-title":"Neuropharmacology"},{"key":"15_CR21_15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646\u20131647","journal-title":"J Am Chem Soc"},{"key":"15_CR22_15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1124\/mol.105.015040","volume":"69","author":"M Gari-Bobo","year":"2006","unstructured":"Gari-Bobo M, Elachouri G, Scatton B et al. (2006) The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increase markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol 69:471\u2013478","journal-title":"Mol Pharmacol"},{"key":"15_CR23_15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00018-006-6445-4","volume":"64","author":"V Gasperi","year":"2007","unstructured":"Gasperi V, Fezza F, Pasquariello N et al. (2007) Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell Mol Life Sci 64:219\u2013229","journal-title":"Cell Mol Life Sci"},{"key":"15_CR24_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.diabet.2007.08.002","volume":"34","author":"M Guerre-Millo","year":"2008","unstructured":"Guerre-Millo M (2008) Adiponectin: an update. Diabetes Metab 34:12\u201318","journal-title":"Diabetes Metab"},{"key":"15_CR25_15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0006-8993(03)03046-4","volume":"983","author":"L Hanus","year":"2003","unstructured":"Hanus L, Avraham Y, Ben-Shushan D et al. (2003) Short term fasting and prolonged semistarvation have opposite effects on 2-AG levels in the mouse brain. Brain Res 983:144\u2013151","journal-title":"Brain Res"},{"key":"15_CR26_15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neulet.2004.10.080","volume":"375","author":"H Hermann","year":"2005","unstructured":"Hermann H, Lutz B (2005) Coexpression of cannabinoid receptor type 1 with the corticotrophin releasing hormone receptor type-1 in distinct region of mouse adult forebrain. Neurosci Lett 375:13\u201318","journal-title":"Neurosci Lett"},{"key":"15_CR27_15","doi-asserted-by":"publisher","first-page":"23731","DOI":"10.1074\/jbc.M212369200","volume":"278","author":"S Hilairet","year":"2003","unstructured":"Hilairet S, Bouaboula M, Carriere D et al. (2003) Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for crosstalk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 278:23731\u201323737","journal-title":"J Biol Chem"},{"key":"15_CR28_15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0014-2999(03)01343-8","volume":"462","author":"AL Hildebrandt","year":"2003","unstructured":"Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Anti-obesity effects of chronic CB1 receptor antagonist treatment in diet induced obese mice. Eur J Pharmacol 462:125\u2013132","journal-title":"Eur J Pharmacol"},{"key":"15_CR29_15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.04-3177fje","volume":"19","author":"O Jbilo","year":"2005","unstructured":"Jbilo O, Ravinet-Trillou C, Arnone M et al. (2005) The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 19:1567\u20131569","journal-title":"FASEB J"},{"key":"15_CR30_15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","volume":"39","author":"P Juan-Pico","year":"2006","unstructured":"Juan-Pico P, Fuentes E, Bermudez-Silva FJ et al. (2006) Cannabinoid receptor regulates Ca(2+) signals and insulin secretion in pancreatic beta-cells. Cell Calcium 39:155\u2013162","journal-title":"Cell Calcium"},{"key":"15_CR31_15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamamuchi T (2005) Adiponectin and adiponectin receptors. Endocrin Rev 26:439\u2013451","journal-title":"Endocrin Rev"},{"key":"15_CR32_15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F et al. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550\u2013557","journal-title":"Br J Pharmacol"},{"key":"15_CR33_15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1389450043490523","volume":"5","author":"C Klaus","year":"2004","unstructured":"Klaus C (2004) Adipose tissue as a regulator of energy balance. Curr Drug Targets 5:241\u2013250","journal-title":"Curr Drug Targets"},{"key":"15_CR34_15","doi-asserted-by":"publisher","first-page":"25196","DOI":"10.1074\/jbc.C500175200","volume":"280","author":"B Kola","year":"2005","unstructured":"Kola B, Hubina E, Tucci SA et al. (2005) Cannabinoids and ghrelin have both central and peripheral metabolic effects via AMP-activated protein kinase. J Biol Chem 280:25196\u201325202","journal-title":"J Biol Chem"},{"key":"15_CR35_15","doi-asserted-by":"crossref","first-page":"e1797","DOI":"10.1371\/journal.pone.0001797","volume":"12","author":"B Kola","year":"2008","unstructured":"Kola B, Farkas I, Christ-Crain M et al. (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE Mar 12; 3:e1797 PMID: 18335063","journal-title":"PLoS ONE Mar"},{"key":"15_CR36_15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.ijo.0802847","volume":"29","author":"YL Liu","year":"2005","unstructured":"Liu YL, Connoley IP, Wilson CA et al. (2005) Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)\/Lep(ob) mice. Int J Obesity 29:183\u2013187","journal-title":"Int J Obesity"},{"key":"15_CR37_15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tem.2006.11.006","volume":"18","author":"I Matias","year":"2007","unstructured":"Matias I, Di Marzo V (2007) Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18:27\u201337","journal-title":"Trends Endocrinol Metab"},{"key":"15_CR38_15","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P et al. (2006) Regulation, function and dysregulation of endocannabinoids in models of adipose and \u03b2-pancreatic cells and in obesity and hyperglicemia. J Clin Endocrinol Metab 91:3171\u20133180","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR39_15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","volume":"30","author":"P Monteleone","year":"2005","unstructured":"Monteleone P, Matias I, Martiadis V et al. (2005) Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30:1216\u20131221","journal-title":"Neuropsychopharmacology"},{"key":"15_CR40_15","first-page":"353","volume":"14","author":"JV Neel","year":"1962","unstructured":"Neel JV (1962) Diabetes mellitus: A \u201cthrifty\u201d genotype rendered detrimental by \u201cprogress\u201d. Am Hum Genet 14:353\u2013362","journal-title":"Am Hum Genet"},{"key":"15_CR41_15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, De Petrillo M, Pacher P et al. (2005a) Endocannabinoids activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet induced obesity. J Clin Invest 115:1298\u20131305","journal-title":"J Clin Invest"},{"key":"15_CR42_15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000087925","volume":"81","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, Depetrillo M, Harvey-White J et al. (2005b) Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of anandamide. Neuroendocrinology 81:273\u2013282","journal-title":"Neuroendocrinology"},{"key":"15_CR43_15","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman D, Liu J, Godlewski G et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118:3160\u20133169","journal-title":"J Clin Invest"},{"key":"15_CR44_15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389\u2013462","journal-title":"Pharmacol Rev"},{"key":"15_CR45_15","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1210\/jc.2007-0768","volume":"92","author":"C Pagano","year":"2007","unstructured":"Pagano C, Pilon C, Calcagno A et al. (2007) The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab 92:4810\u20134819","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR46_15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"U Pagotto","year":"2006","unstructured":"Pagotto U, Marsicano G, Cota D et al. (2006) The emerging role of endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27:73\u2013100","journal-title":"Endocr Rev"},{"key":"15_CR47_15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-2006-925401","volume":"38","author":"N Perwitz","year":"2006","unstructured":"Perwitz N, Fasshauer M, Klein J (2006) Cannabinoid receptor signalling directly inhibits thermogenesis and alters expression of adiponectin and visfatin. Horm Metab Res 38:356\u2013358","journal-title":"Horm Metab Res"},{"key":"15_CR48_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-59259-710-9_1","volume-title":"Marihuana and medicine","author":"H Peters","year":"1999","unstructured":"Peters H, Nahas GG (1999) A brief history of four millennia (B.C.2000\u2013A.D. 1974). In: Nahas GG, Sutin K, Harvey D, Agurell S (eds) Marihuana and medicine. Humana Press Inc, Totowa (NJ), pp 3\u20137"},{"key":"15_CR49_15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873\u2013884","journal-title":"Nat Rev Neurosci"},{"key":"15_CR50_15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J for the RIO-North America Study Group","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J for the RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761\u2013775","journal-title":"JAMA"},{"key":"15_CR51_15","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","volume":"284","author":"C Ravinet Trillou","year":"2003","unstructured":"Ravinet Trillou C, Arnone M, Delgorge C et al. (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet induced obese mice. Am J Physiol Regul Integr Comp Physiol 284:R345\u2013R353","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"15_CR52_15","unstructured":"Rosenstock J, Hollander P, Chevalier S, Iranmanesh A for the SERENADE study group (2008) The SERENADE trial: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight and lipid profile in drug-naive type 2 diabetes. Diabetes Care Aug 4. PMID: 18678611"},{"key":"15_CR53_15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","volume":"368","author":"Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF for the RIO-Diabetes Study Group","year":"2006","unstructured":"Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF for the RIO-Diabetes Study Group (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368:1660\u20131672","journal-title":"Lancet"},{"key":"15_CR54_15","first-page":"179","volume":"9","author":"J Simi","year":"1998","unstructured":"Simiand J, Keane M, Keane PE et al. (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179\u2013181","journal-title":"Behav Pharmacol"},{"key":"15_CR55_15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/oby.2007.106","volume":"16","author":"KA Starowicz","year":"2008","unstructured":"Starowicz KA, Cristino L, Matias I et al. (2008) Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 16:553\u2013565","journal-title":"Obesity"},{"key":"15_CR56_15","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db07-1623","volume":"57","author":"L Tedesco","year":"2008","unstructured":"Tedesco L, Valerio A, Cervino C et al. (2008) Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57:2028\u20132036","journal-title":"Diabetes"},{"key":"15_CR57_15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/CS20070196","volume":"114","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR (2008) Role of adiponectin and PBEF\/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 114:275\u2013288","journal-title":"Clin Sci (Lond)"},{"key":"15_CR58_15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/sj.bjp.0705968","volume":"143","author":"SA Tucci","year":"2004","unstructured":"Tucci SA, Rogers EK, Korbonits M et al. (2004) The cannabinoid receptor antagonist SR141716 blocks the orexigenic effect of intrahypothalamic ghrelin. Br J Pharmacol 143:520\u2013523","journal-title":"Br J Pharmacol"},{"key":"15_CR59_15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, R\u00f6ssner S for the RIO-Europe Study Group","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, R\u00f6ssner S for the RIO-Europe Study Group (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389\u20131397","journal-title":"Lancet"},{"key":"15_CR60_15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","volume":"76","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002) Observational analysis of feeding induced by \u03949-THC and anandamide. Physiol Behav 76:241\u2013250","journal-title":"Physiol Behav"},{"key":"15_CR61_15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.neuron.2005.10.021","volume":"48","author":"JH Yo","year":"2005","unstructured":"Yo JH, Chen YJ, Talmage DA et al. (2005) Integration of leptin signalling in an appetite-related neural circuit. Neuron 48:1055\u20131066","journal-title":"Neuron"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of the Endocannabinoid System"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-88955-7_15.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T12:13:09Z","timestamp":1619525589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-88955-7_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540889540","9783540889557"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-88955-7_15","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"type":"print","value":"1866-3370"},{"type":"electronic","value":"1866-3389"}],"subject":[],"published":{"date-parts":[[2009]]}}}